Ken Griffin Ocugen, Inc. Transaction History

Citadel Advisors LLC

$618 Billion
Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ocugen, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,568,211 shares of OCGN stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,568,211

Previous 602,014 160.49%

Holding current value

$1.87 Million

Previous $583,000 338.42%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.92 - $1.66 $888,901 - $1.6 Million	966,197 Added 160.49%	1,568,211 $2.56 Million
Q2 2025 Aug 14, 2025	BUY	$0.58 - $1.2 $205,752 - $425,695	354,746 Added 143.47%	602,014 $583,000
Q1 2025 May 15, 2025	BUY	$0.52 - $0.9 $54,330 - $94,032	104,481 Added 73.17%	247,268 $175,000
Q4 2024 Feb 14, 2025	BUY	$0.72 - $1.08 $102,806 - $154,209	142,787 New	142,787 $114,000
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $168 - $614	336 New	336 $0
Q2 2023 Aug 14, 2023	BUY	$0.45 - $0.88 $125,755 - $245,922	279,457 Added 95.1%	573,323 $309,000
Q1 2023 May 15, 2023	BUY	$0.82 - $1.33 $26,684 - $43,280	32,542 Added 12.45%	293,866 $249,000
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.87 $25,042 - $42,189	22,561 Added 9.45%	261,324 $339,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $347,831 - $616,159	198,761 Added 496.88%	238,763 $425,000
Q2 2022 Aug 15, 2022	SELL	$1.83 - $3.45 $66,793 - $125,921	-36,499 Reduced 47.71%	40,002 $91,000
Q1 2022 May 16, 2022	SELL	$2.34 - $4.72 $865,107 - $1.75 Million	-369,704 Reduced 82.86%	76,501 $252,000
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $53,440 - $191,189	-12,201 Reduced 2.66%	446,205 $2.03 Million
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $1.46 Million - $1.95 Million	229,510 Added 100.27%	458,406 $3.29 Million
Q2 2021 Aug 16, 2021	SELL	$5.52 - $15.68 $3.2 Million - $9.09 Million	-579,761 Reduced 71.69%	228,896 $1.84 Million
Q1 2021 May 17, 2021	BUY	$1.66 - $15.81 $1.32 Million - $12.6 Million	794,773 Added 5724.38%	808,657 $5.49 Million
Q4 2020 Feb 16, 2021	BUY	$0.28 - $2.6 $3,887 - $36,098	13,884 New	13,884 $25,000
Q3 2020 Nov 16, 2020	SELL	$0.2 - $0.72 $93,194 - $335,499	-465,972 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.22 - $0.46 $74,530 - $155,836	338,774 Added 266.34%	465,972 $103,000
Q1 2020 May 15, 2020	BUY	$0.26 - $0.73 $33,071 - $92,854	127,198 New	127,198 $36,000

Others Institutions Holding OCGN

# of Institutions

108

Shares Held

60.5M

Call Options Held

531K

Put Options Held

433K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $258M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account